Compare, Analyse AANJANEYA LIFECARE with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. DATSONS LABS   ACTAVIS
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ACTAVIS
Dec-18
DR. DATSONS LABS/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs12614,478-   
Low Rs319,712-   
Sales per share (Unadj.) Rs133.03,551.4-  
Earnings per share (Unadj.) Rs0.2-1,143.9-  
Cash flow per share (Unadj.) Rs6.6374.2-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.814,647.7-  
Shares outstanding (eoy) m31.66332.60-   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.63.4 17.3%   
Avg P/E ratio x516.1-10.6 -4,881.4%  
P/CF ratio (eoy) x11.832.3 36.6%  
Price / Book Value ratio x0.60.8 73.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,4774,022,682 0.1%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m560-   
Avg. sales/employee Rs ThNM69,892.5-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM-22,512.4-  
INCOME DATA
Net Sales Rs m4,2111,181,183 0.4%  
Other income Rs m7922,588 0.3%   
Total revenues Rs m4,2891,203,771 0.4%   
Gross profit Rs m56930,953 1.8%  
Depreciation Rs m204504,930 0.0%   
Interest Rs m43068,161 0.6%   
Profit before tax Rs m13-519,550 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0132,506 0.0%   
Tax Rs m6-6,584 -0.1%   
Profit after tax Rs m5-380,460 -0.0%  
Gross profit margin %13.52.6 515.3%  
Effective tax rate %48.01.3 3,790.1%   
Net profit margin %0.1-32.2 -0.4%  
BALANCE SHEET DATA
Current assets Rs m6,852484,460 1.4%   
Current liabilities Rs m6,711428,569 1.6%   
Net working cap to sales %3.34.7 70.8%  
Current ratio x1.01.1 90.3%  
Inventory Days Days16120 821.3%  
Debtors Days Days31866 480.3%  
Net fixed assets Rs m3,673133,703 2.7%   
Share capital Rs m3170-   
"Free" reserves Rs m3,7610-   
Net worth Rs m4,0784,871,829 0.1%   
Long term debt Rs m1,6711,715,548 0.1%   
Total assets Rs m12,6337,615,778 0.2%  
Interest coverage x1.0-6.6 -15.5%   
Debt to equity ratio x0.40.4 116.4%  
Sales to assets ratio x0.30.2 214.9%   
Return on assets %3.4-4.1 -84.0%  
Return on equity %0.1-7.8 -1.5%  
Return on capital %7.7-4.8 -158.5%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Net fx Rs m3570-   
CASH FLOW
From Operations Rs m1,345421,992 0.3%  
From Investments Rs m-2,256231,830 -1.0%  
From Financial Activity Rs m-1,200-724,265 0.2%  
Net Cashflow Rs m-2,111-70,091 3.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 74.82 Rs / USD

Compare DR. DATSONS LABS With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare DR. DATSONS LABS With: STRIDES PHARMA SCIENCE  LUPIN  FULFORD INDIA  NOVARTIS  SUVEN LIFE SCIENCES  



Today's Market

Sensex Trades Marginally Higher, Dow Futures Down by 28 Points(12:30 pm)

Share markets in India are presently trading marginally higher. The BSE Sensex is trading up by 74 points, up 0.2% at 48,877 levels.

Related Views On News

Nazara Technologies IPO: Should You Apply? (IPO)

Mar 17, 2021

Should you bet on this gaming company backed by ace investor Rakesh Jhunjhunwala?

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

An India Revival Stock I'm Bullish On... (Profit Hunter)

Apr 9, 2021

This could take India to the position of 3rd largest economy.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

Why the Market Fell Yesterday (Fast Profits Daily)

Apr 6, 2021

In this video, I'll tell you the two reasons why the market fell on Monday and how you can prepare yourself for such events in the future.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - PROCTER & GAMBLE HEALTH COMPARISON

COMPARE DR. DATSONS LABS WITH

FEATURED VIDEOS

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

Nifty: Bear Trap?

More Featured Videos

MARKET STATS